Dive Brief: After a surprise billing ban went into effect in California, the share of services delivered out-of-network by affected specialties declined by 17%, according to a new analysis by the USC-Brookings Schaeffer Initiative for Health Policy. The drop was primarily focused in the third quarter of 2017, immediately after the law was implemented. The… Read More »
A no-deal Brexit presents risks to the NHS and care homes despite extensive government planning, a watchdog says. The National Audit Office praised the government for the “enormous amount of work” that had been done but said there were still “significant” gaps. The extra shipping capacity government was buying to bring medicines into ports other… Read More »
Following recent statewide bans on specific varieties of e-cigarettes as a result of hundreds of illnesses and several deaths across the country, new findings published in Scientific Reports are shedding light on how some e-cig flavors could worsen symptoms of asthma and other respiratory diseases, reports EurekAlert! For the study, researchers from Australia and the… Read More »
Valisure: “Valisure Citizen Petition on Ranitidine.” Sandoz Inc.: “Sandoz Inc. Issues Voluntary Recall of Ranitidine Hydrochloride Capsules 150mg and 300mg Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA), in the Product.” Bloomberg: “Carcinogen in Zantac Leads to Another Shipment Halt, Recall.” Health Canada: “Health Canada requests that companies stop distributing ranitidine drugs in… Read More »